The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, Y.
Right arrow Articles by Myrvik, Q. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, Y.
Right arrow Articles by Myrvik, Q. N.
The Journal of Immunology, 2000, 164: 1314-1321.
Copyright © 2000 by The American Association of Immunologists

Oral Administration of Chitin Down-Regulates Serum IgE Levels and Lung Eosinophilia in the Allergic Mouse1

Yoshimi Shibata2,*, L. Ann Foster{ddagger}, John F. Bradfield{dagger} and Quentin N. Myrvik§

Departments of * Physiology and {dagger} Comparative Medicine, East Carolina University School of Medicine, Greenville, NC 27858; {ddagger} Department of Biology, Southern Adventist University, Collegedale, TN 37315; and § Myrvik Enterprises, Southport, NC 28461


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies showed that local macrophages phagocytose nonantigenic chitin particles (1–10 µm polymers of N-acetyl-D-glucosamine) through mannose receptors and produce IL-12, IL-18, and TNF-{alpha}. These cytokines lead to the production of IFN-{gamma} by NK cells. To determine whether chitin could down-regulate Th2 responses, chitin was given orally (8 mg/day for 3 days before and 13 days during ragweed allergen immunization) in BALB/c and C57BL/6 mice. These ragweed-immunized mice were given ragweed intratracheally on day 11. Three days after the challenge, the immunized mice with saline (controls) showed increases in serum IgE levels and lung eosinophil numbers. The chitin treatment resulted in decreases of these events in both strains. To dissect the inhibitory mechanisms of Th2 responses, spleen cells (4 x 106 cells/ml) isolated from the ragweed-immunized mice (controls) were cultured in the presence of ragweed and/or chitin for 3 days (recall responses). Ragweed alone stimulated the production of IL-4 (0.6 ng/ml), IL-5 (20 U/ml), and IL-10 (3.2 ng/ml), but not IFN-{gamma}. Ragweed/chitin stimulation resulted in significant decreases of IL-4, IL-5, and IL-10 levels and the production of IFN-{gamma} (48 U/ml). Moreover, spleen cells isolated from the chitin-treated mice showed ragweed-stimulated IFN-{gamma} production (15 U/ml) and significantly lower levels of the Th2 cytokines, suggesting that the immune responses were redirected toward a Th1 response. Collectively, these results indicate that chitin-induced innate immune responses down-regulate Th2-facilitated IgE production and lung eosinophilia in the allergic mouse.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Serial prevalence studies have shown that childhood allergic diseases including asthma are becoming more common. A probable explanation for the increase is due to the effects of life in the industrialized world, resulting in an increase in exposure to exogenous factors (outdoor and indoor pollutants, cigarette smoke, and allergen exposure) that may induce asthma, a reduction in host resistance, or a combination of both mechanisms. Factors altering host resistance have received less attention (1). A recent study by Shirakawa et al. (2) on children in Wakayama, Japan, suggested that tuberculosis was instrumental in reducing atopic disease prevalence. This study demonstrated a marked decline in the incidence of positive tuberculin responses (95% in 1965 and 58% in 1995) and tuberculosis (154.4 per 100,000 in 1974 and 52.1 per 100,000 in 1994). This information, therefore, suggested that the enhancement of Th1 immune responses by appropriate vaccines may be therapeutically beneficial against asthma and allergic diseases.

Inflammation in allergic asthma is generated and activated by endogenous proinflammatory cytokines produced by Th2-type lymphocytes: IL-4 facilitates IgE production and humoral immunity; IL-5 facilitates replication and activation of eosinophils. These allergen-induced Th2 responses enhance airway hyperreactivity in mouse models, although the mechanism(s) appears to be multifactorial depending on mouse strains (3, 4, 5). In contrast, the development of Th1/cell-mediated immunity responses induced by intracellular bacterial infection is characterized by the initial production of IL-12, TNF-{alpha}, and IL-18 by macrophages (M{phi})3 phagocytosing bacteria. These M{phi} cytokines subsequently induce IFN-{gamma} production by NK cells and Th1 lymphocytes. It is of importance that Th1 cytokines reverse Th2 cell-facilitating allergic inflammation. Particularly, the administration of exogenous IFN-{gamma} or IL-12 appears to inhibit such IL-4/IL-5-associated allergic asthma responses in patients and allergic animal models (6, 7, 8).

Recently, we have studied the mechanisms of innate immunity induced by heat-killed (HK) Mycobacterium bovis BCG or Propionibacterium parvum. We have found that when M{phi} phagocytose bacteria or their products through the M{phi} mannose receptors, they initiate production of IL-12, IL-18, and TNF-{alpha}, all of which are extracellular signaling cytokines for IFN-{gamma} production (9, 10, 11). To imitate this response, we have created nonantigenic mimetic microbes consisting of 1–10 µm chitin (polymers of N-acetyl-D-glucosamine) particles, which are recognized and ingested by M{phi} through the mannose receptor (11). Our previous study (10) clearly indicated that 1–10 µm chitin particles, but not soluble chitin or nonphagocytosable size particles (>50 µm), induce the production of Th1 cytokines including IFN-{gamma} in vitro and in vivo in mouse models. The capacity to induce Th1 cytokines by chitin is comparable with that induced by HK-BCG or HK-Propionibacterium acnes suspensions (9, 11). In contrast, other phagocytosable particles, such as chitosan, ß-glucan, latex beads, IgG-opsonized SRBC, and complement (C3bi)-opsonized SRBC, do not induce Th1 cytokines (11, 12).

To evaluate the potential for chitin to down-regulate allergic inflammation in vivo, we utilized a mouse model of allergic airway inflammation elicited by ragweed allergen clinically relevant to human asthma (6). Chitin preparations were given orally. In this study, we present the results of the chitin treatment as an attractive therapy for IgE-mediated (allergic) diseases.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

BALB/c and C57BL/6 female mice (6–7 wk old) were obtained from Harlan Laboratory (Indianapolis, IN) and The Jackson Laboratory (Bar Harbor, ME), respectively, maintained in barrier-filtered cages, and fed Purina Laboratory Chow and tap water ad libitum.

Chitin particle preparation

Chitin particles (1–10 µm diameter) were prepared from purified chitin powders (Sigma, St. Louis, MO), as described previously (10, 13), suspended in saline (10–16 mg/ml), autoclaved, and stored at 4°C until use. The chitin preparations contained undetectable levels of endotoxin (<0.03 EU/ml), as determined by the Limulus amebocyte lysate assay (Sigma).

Immunization of mice with ragweed

Mice were sensitized with ragweed allergen, as described previously (6). The schedule of the sensitization is shown in Table IGo. Briefly, mice were immunized with two i.p. injections of endotoxin-free ragweed allergen (<0.03 EU/ml; Geer Laboratories, Lenoir, NC), 100 µg/dose (5000 protein nitrogen units/dose) suspended in 1:4 aluminum hydroxide adjuvant (Imject Alum; Pierce, Rockford, IL) on days 0 and 4. Eleven days after the initial sensitization, an i.t. challenge was performed with 100 µg of ragweed allergen. Control groups included unimmunized mice receiving i.t. challenge of 0.1 ml of saline (naive I) or ragweed 100 µg (naive II) on day 11. After 3 days, unless indicated otherwise, mice were humanely sacrificed, and the blood, spleens, BAL cells, and lungs were harvested.


View this table:
[in this window]
[in a new window]
 
Table I. Schedule of immunization and challenge of ragweed and oral administration of chitin1

 
BAL eosinophils and other inflammatory cells were enumerated by differential counts following cytospin preparations and staining with Diff-Quik. Following BAL, the lungs were removed, Formalin fixed, and used for histological analysis, as described below. Spleen cells were utilized for recall responses, as described below. Serum IgE levels were determined by ELISA, as described below.

Oral administration of chitin

As shown in Table IGo, allergic mice (6–7 mice/group) were given chitin (5–8 mg/mouse/day) orally on days -3 to 13 (group 1). Chitin was given 4 h before i.t. challenge of ragweed on day 11. Control mice received saline (0.5 ml/day) (group 3). In some experiments, allergic mice received chitin on days 12 and 13 (group 2).

Endotoxin removal

It was noticed that the presence of endotoxin in some allergen preparations caused neutrophilia (rather than eosinophilia) following pulmonary allergen challenge in patients with asthma (14). Endotoxin induces the production of inflammatory mediators including IL-12, IL-18, and TNF-{alpha} (9), major targets in this study. To remove possibly contaminating endotoxin, all soluble materials including ragweed preparations were passed through 0.22-µm Zetapor membrane filters (Cuno, Meriden, CT) manufactured for this purpose (15). The effectiveness of endotoxin removal was monitored by the Limulus amebocyte lysate assay (Sigma).

Cytokine production in recall responses: spleen cell cultures stimulated with ragweed allergen in the presence or absence of chitin

Spleens were isolated from ragweed-sensitized/challenged mice (3 days after the challenge) and naive I control mice. Spleens in each group were pooled. Spleen cells (4 x 106 cells/ml) suspended in RPMI 1640 plus 10% heat-inactivated FBS were incubated with ragweed at 10 µg/ml and/or chitin at 100 µg/ml at 37°C for 3 to 4 days in a CO2 incubator. After the incubation, the culture supernatants were collected and their selected cytokine levels (IL-4, IL-5, IL-10, IFN-{gamma}) were determined by their respective specific ELISA assays (9).

In some experiments, CD4+ cells and asialo GM1+ NK cells were eliminated with Abs against CD4 (clone GK1.5; American Type Culture Collection, Manassas, VA) and asialo GM1+ (rabbit polyclonal; Accurate Chemical, Westbury, NY), respectively, followed by treatment with guinea pig serum (1:10; Accurate) as a source of complement. The expression of CD4 and DX5 (pan NK cell marker) was determined by indirect immunofluorescence by the staining with anti-CD4 mAb and anti-DX5 mAb (PharMingen, San Diego, CA) in the presence of 5% heat-inactivated newborn calf serum (Life Technologies, Grand Island, NY), pH 7.2, as described previously (9).

To assess regulatory roles of endogenous cytokines (IL-4, IL-10, IFN-{gamma}), neutralizing Abs for these cytokines (Endogen, Woburn, MA) were added to the ragweed-stimulated spleen cell cultures.

Detection of total IgE and ragweed-specific IgE and IgG2a Abs in sera

Ragweed-immunized allergic responses were monitored by measuring total IgE levels. Blood (5 µl/mouse/interval) was collected from the tail vein, and serum IgE levels were detected by ELISA using purified mouse IgE {kappa} isotype (PharMingen) as a standard. Ragweed-specific IgE and IgG2a levels were measured by ELISA with ragweed Ag-coated 96-well plates; 5 µg ragweed/0.1 ml/well in 0.1 M sodium acetate buffer, pH 6.5, overnight at 4°C (16). For the detection, alkaline phosphatase-labeled anti-IgE and anti-IgG2a were used. The enzyme substrate was p-nitrophenylphosphate: optical absorbance at 405 nm was read.

Lung histology

Lungs were removed on day 14 and immediately fixed with 10% neutral-buffered Formalin. The fixed lungs were embedded in paraffin, sectioned at a thickness of 4 µm, and stained with hematoxylin and eosin. The slides were evaluated for any abnormalities by a pathologist blinded to the treatment groups. The degree of allergen-induced peribronchial and perivascular inflammation was graded on a subjective scale of 0, 1, 2, 3, and 4 corresponding to severity nomenclature of absent, mild, moderate, marked, or severe, respectively (17).

Statistics

Differences between mean values were analyzed by unpaired Student’s t test. p values less than 0.05, which were calculated as two-tailed p values, were considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The release of IL-4, IL-5, and IL-10 production in ragweed-induced recall responses ex vivo is inhibited by chitin

To assess whether chitin modulates the production of selected Th2 cytokines, spleen cells were isolated from the spleens of ragweed-sensitized BALB/c mice and incubated with ragweed allergen and/or chitin. When spleen cells from ragweed-sensitized mice were rechallenged with ragweed allergen ex vivo (recall responses), they released significant levels of IL-4, IL-5, and IL-10, but not IFN-{gamma} (Fig. 1Go). Control spleen cells from unimmunized mice (naive I) did not respond to the allergen. As previously reported (9), when normal spleen cells were incubated with chitin alone at 100 µg/ml, they produced IFN-{gamma} and IL-10, but not IL-4 or IL-5 (Fig. 1Go). Chitin also stimulated spleen cells from ragweed-sensitized mice to produce IFN-{gamma} and IL-10, but not IL-4 or IL-5. Finally, when ragweed-sensitized spleen cells were stimulated simultaneously with ragweed and chitin, the levels of IL-4, IL-5, and IL-10 produced were significantly reduced compared with those stimulated by ragweed alone. IFN-{gamma} levels were also significantly reduced compared with those stimulated by chitin alone.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 1. Chitin inhibits IL-4/IL-5/IL-10 production by spleen cells from ragweed-immunized mice. BALB/c mice were sensitized with endotoxin-free ragweed with the protocol indicated in Table IGo. Spleens were isolated and pooled 3 days after the i.t. challenge of ragweed. Control spleens were isolated from unimmunized mice (naive I control). Spleen cells (4 x 106 cells/ml) were cultured in the presence of ragweed (RW, 10 µg/ml), chitin (100 µg/ml), or ragweed mixed with chitin (RW/chitin) for 3 days. The levels of indicated cytokines in the supernatants were measured by ELISA. Mean ± SD in triplicate cultures. {square} and {blacksquare}, Naive control and ragweed-immunized mice, respectively. *, p < 0.05, and #, p < 0.0005 compared with the cytokine levels induced by ragweed (RW) alone and chitin alone, respectively. The data shown are representative of three independent experiments.

 
To characterize cell populations responding to ragweed allergen or chitin, either CD4 cells or NK cells were eliminated by specific Abs, followed by complement-dependent cell lysis. CD4 cell- and NK cell-eliminated spleen cells contained 0.5% CD4+ cells and 0.3% DX5+ cells, respectively (data not shown). As shown in Fig. 2Go, when CD4 cells were eliminated, ragweed-stimulated IL-4, IL-5, and IL-10 production was significantly impaired, whereas chitin-induced IFN-{gamma} production was still intact. In contrast, when asialo GM1+ NK cells were eliminated, ragweed-induced IL-4, IL-5, and IL-10 production was intact, but chitin-induced IFN-{gamma} production was diminished (Fig. 2Go). Interestingly, when NK cell-eliminated spleen cells were stimulated simultaneously by ragweed and chitin, the down-regulation of IL-4/IL-5/IL-10 production by chitin was not observed (Fig. 2Go).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 2. Roles of CD4 cells and NK cells in the recall responses stimulated by ragweed allergen and/or chitin. Spleen cells described in Fig. 1Go were pretreated with either guinea pig serum alone as a source of complement (C', {blacksquare}), anti-CD4 plus guinea pig serum ({square}), or antiasialo GM1 (anti-aGM1) plus guinea pig serum (), and were resuspended in RPMI 1640 plus 10% FBS at 4 x 106 cells/ml. The remaining procedures of the recall responses were identical to those described in Fig. 1Go. The levels of indicated cytokines in the supernatants are presented. Mean ± SD in triplicate cultures. The data shown are representative of three independent experiments.

 
Taken together, these results suggest that IL-4 and IL-5 are produced by ragweed Ag-specific CD4+ Th2 spleen cells. When costimulated with chitin, Th1 cytokines including IFN-{gamma} produced by NK cells appear to inhibit the Th2 cytokine production. It is likely, therefore, that the administration of chitin in the allergic mouse will down-regulate the allergen-induced Th2 immune responses.

The prophylactic effects of chitin administration in the allergic BALB/c mouse

Mice immunized with ragweed at the schedule shown in Table IGo had been established by Sur et al. (6), and showed high levels of total serum IgE and lung inflammation including eosinophilia. To assess whether chitin administration down-regulates these inflammatory parameters, ragweed-sensitized mice were given chitin orally on days -3 to 13 (group 1 in Table IGo).

As shown in Fig. 3GoA, a significant elevation of serum IgE levels was observed after day 8. The levels increased to 4607 ± 1086 ng/ml on day 14. When mice were treated with chitin, the levels were significantly reduced (2014 ± 939 ng/ml, p < 0.0005). Ragweed-specific IgE levels were also reduced significantly by the chitin treatment, whereas ragweed-specific IgG2a levels were enhanced by the chitin treatment (Fig. 3GoB). The inhibition of total IgE levels was also observed on days 8, 10, and 12. Less than 50 ng/ml was detected on day 14 in naive I and naive II controls.



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 3. The effects of chitin treatment on serum IgE levels in ragweed-sensitized BALB/c mice. Groups of BALB/c mice (seven mice/group) were given chitin (8 mg/mouse/day) orally 3 days before ragweed immunization and continued to receive chitin during the immunization periods (group 1 in Table IGo). Immunized mice receiving saline (0.5 ml/mouse/day) served as controls (group 3). Blood samples were collected from tail veins at indicated days. A, Total serum IgE levels in the chitin-treated group ({square}) and in the saline-treated control group ({blacksquare}) were measured by ELISA. Mean ± SD, n = 7. *, p < 0.05; **, p < 0.01; #, p < 0.0005 compared with the saline-treated group. B, Ragweed-specific IgE ({blacksquare}) and IgG2a levels ({square}) in sera isolated from unimmunized groups (naive I controls, naive II controls) and ragweed-immunized groups (saline treated, chitin treated) on day 14 were quantified as described in Materials and Methods. The sera were diluted 1/5 and 1/20 with saline before they were assayed for ragweed-specific IgE and IgG2a levels, respectively. Mean ± SD, n = 7. *, p < 0.01; #, p < 0.0005 compared with the saline-treated group.

 
BAL cells were harvested on day 14. Control groups (naive I, naive II) showed less than 3 x 105 total nucleated cells that contained >95% M{phi}, 3% of lymphocytes, and <2% neutrophils (data not shown). As shown in Fig. 4Go, i.t. challenge of ragweed allergen in ragweed-immunized mice resulted in the migration of lymphocytes, eosinophils, and neutrophils in BAL fluid. The eosinophil and lymphocyte levels were reduced significantly by the chitin treatment (Fig. 4Go).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 4. The effect of chitin treatment on ragweed-induced eosinophilia in BAL (BALB/c mice). BAL was collected from the saline-treated control group ({blacksquare}), chitin-treated group (days -3 to 13, {square}), and chitin-treated group (days 12 and 13, ) of immunized BALB/c mice on day 14. The numbers of lymphocytes (Lymph), eosinophils (Eo), neutrophils (Neut), and macrophages (Mac) were determined as described in Materials and Methods. Mean ± SD, n = 7. *, p < 0.05; #, p < 0.005; ##, p < 0.0005 compared with the saline-treated group.

 
Total lung inflammation on day 14 was determined histologically and defined as the sum of peribronchial and perivascular inflammation scores. Fig. 5Go, A (naive II control), B (saline, group 3), and C (chitin, group 1), show representative hematoxylin and eosin-stained peribronchial and perivascular areas of the lungs (x40). Naive animals had no detectable lung inflammation, whereas the allergic mice treated with saline (group 3) had significant peribronchial and perivascular inflammation. Compared with the saline group, the peribronchial, the perivascular, and total lung inflammation were inhibited in the chitin-treated group (Table IIGo).



View larger version (87K):
[in this window]
[in a new window]
 
FIGURE 5. The effects of chitin on peribronchial and perivascular lung inflammation. Shown are photographs of lung sections from representative naive mice (A, naive II in Table IGo), saline-treated allergic mice (B, group 3), and chitin-treated allergic mice (C, group 1) at x40 magnification. The lung of a naive mouse (A) showed no peribronchial or perivascular inflammation. In contrast, the lung of a mouse from the saline-treated group (B) showed grade 4 peribronchial inflammation, grade 4 perivascular inflammation, and grade 8 total lung inflammation. The lung from a mouse in the chitin-treated group (C) showed grade 1 peribronchial inflammation, grade 1 perivascular inflammation, and grade 2 total lung inflammation.

 

View this table:
[in this window]
[in a new window]
 
Table II. Effects of chitin on peribronchial and perivascular lung inflammation

 
Although BAL fluid on day 14 did not have detectable levels of IL-4 or IFN-{gamma} in the chitin-treated group (group 1) and saline-treated control (group 3) (data not shown), we monitored IL-4 and IFN-{gamma} levels in BAL fluid on day 12 (Fig. 6Go). BAL contained IL-4 at 613 pg/ml and IFN-{gamma} at <5 U/ml in saline-treated group (group 3). The chitin treatment (group 1) showed significant inhibition of IL-4 levels (163 pg/ml) and enhancement of IFN-{gamma} levels (19.5 U/ml) (Fig. 6Go). IL-5 and IL-10 levels were not detected in BAL fluid of these two groups obtained on either day 12 or 14 (data not shown).



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 6. The effects of chitin treatment on IL-4 and IFN-{gamma} levels in BAL of allergic BALB/c mice. Groups of BALB/c mice (six mice/group) were given chitin (8 mg/mouse/day) orally 3 days before ragweed immunization and continued to receive chitin 11 days during the immunization periods. Immunized mice receiving saline (0.5 ml/mouse/day) served as controls. Mice received ragweed challenged i.t. on day 11; BAL fluid was harvested on day 12. IL-4 and IFN-{gamma} levels in BAL fluid were measured by ELISAs. Mean ± SD, n = 6. *, p values indicated were compared between the groups treated with saline and chitin.

 
It should be noted that mice that received chitin orally exhibited a slight weight gain (Table IIIGo) and showed no distress or systemic toxicity. The activity of chitin to induce IL-12, IL-18, TNF-{alpha}, and IFN-{gamma} production by normal mouse spleen cells in vitro was unchanged when chitin was preexposed to 0.1 M hydrochloric acid (pH 1.8) at 37°C for 4 h (data not shown).


View this table:
[in this window]
[in a new window]
 
Table III. Growth of mice given chitin particles orally1

 
The therapeutic effects of chitin administration in the allergic BALB/c mouse

Since serum IgE levels at the sensitization phase were inhibited by the prophylactic treatment with chitin (Fig. 3GoA), we further determined whether the chitin treatment at the effector phase of allergic inflammation is still effective. Chitin was given only on days 12 and 13 (group 2 in Table IGo) when total serum IgE levels were relatively high (1000–2800 ng/ml). As shown in Fig. 7Go, the chitin treatment resulted in significant decrease of IgE levels on day 14. There were significant decreases of lymphocyte and eosinophil numbers in BAL on day 14 (Fig. 4Go). These results suggest that chitin appears to have therapeutic effects.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 7. The therapeutic effect of chitin treatment on serum IgE levels in ragweed-sensitized BALB/c mice. Groups of BALB/c mice (seven mice/group) were given chitin (8 mg/mouse/day) orally on days 12 and 13 ({square}, group 2 in Table IGo). Immunized mice receiving saline (0.5 ml/mouse/day) served as controls ({blacksquare}, group 3). Serum samples were prepared on days 13 and 14. Total serum IgE levels were measured by ELISA. Mean ± SD, n = 7. **, p < 0.01 compared with saline controls.

 
Chitin-treated mouse spleen cells decreased ragweed-stimulated IL-4, IL-5, and IL-10 production (recall responses) and increased ragweed-stimulated IFN-{gamma} production

Prophylactic treatment with chitin. To determine whether ragweed allergen-specific Th2 cell functions were modulated by the prophylactic treatment with chitin (group 1 in Table IGo), recall responses of spleen cells were conducted. As shown in Fig. 8Go, ragweed-stimulated IL-4, IL-5, and IL-10 production was significantly reduced by the chitin treatment, whereas slight but significant amounts of IFN-{gamma} were detected. The production of either IFN-{gamma} or IL-4/IL-5/IL-10 was not observed when spleen cells (group 1) were depleted of CD4+ cells by anti-CD4 plus guinea pig serum before the recall responses (data not shown).



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 8. Chitin-treated mouse spleen cells decreased ragweed-stimulated IL-4, IL-5, and IL-10 production and increased ragweed-stimulated IFN-{gamma} production. Spleen cells were isolated from the groups (saline treated ({blacksquare}, group 3 in Table IGo), chitin treated ({square}, group 1)) of allergic BALB/c mice on day 14 and stimulated ex vivo with ragweed at 10 µg/ml for 4 days. Some cultures contained anti-IL-4 rat IgG2b (1D11 clone; Endogen), anti-IL-10 rat IgG1 (2A5 clone; Endogen), anti-IFN-{gamma} rat IgG1 (XMG1.2), or rat Ig (Sigma) at 20 µg/ml. The levels of IL-4, IL-5, IL-10, and IFN-{gamma} in the culture supernatants were measured by ELISA, as indicated in Materials and Methods. Mean ± SD in triplicate cultures. *, p < 0.05; **, p < 0.01 compared with the saline control group. #, p < 0.05; ##, p < 0.01 compared with the rat Ig-treated groups. The data shown are representative of three independent experiments.

 
IL-4/IL-10 and IFN-{gamma} are known to down-regulate Th1 and Th2 responses, respectively (9, 10, 18, 19, 20). IL-10 also inhibits allergen-stimulated IL-4 and IL-5 production (21). To assess regulatory roles of these endogenous cytokines (IL-4, IL-10, IFN-{gamma}), neutralizing Abs for these cytokines at 20 µg/ml were added to the ragweed-stimulated spleen cell cultures. When rat Ig at 20 µg/ml was added to the cultures as a control, the cytokine profiles were identical to those untreated (data not shown). Fig. 8Go shows that ragweed-stimulated IL-4/IL-5 production by spleen cells was significantly enhanced by either anti-IL-10 or anti-IFN-{gamma} treatments in the chitin groups, suggesting that endogenous IL-10 and IFN-{gamma} inhibit IL-4/IL-5 production. Ragweed-stimulated IL-4/IL-5/IL-10 production by spleen cells from chitin-treated mice was also enhanced by anti-IFN-{gamma} treatments. However, the treatment with anti-IFN-{gamma} did not enhance IL-4/IL-5/IL-10 production in allergic mice given saline (group 3). It is likely, therefore, that endogenous IFN-{gamma} produced by spleen cells from chitin-treated mice inhibits production of these Th2 cytokines. Finally, the treatment with either anti-IL-4 or anti-IL-10 resulted in significant increases in ragweed-stimulated IFN-{gamma} production. It is suggested that the immunized mice generate ragweed-specific Th1 cells when they were prophylactically treated with chitin.

Therapeutic treatment with chitin. Unlike the prophylactic treatment, the therapeutic treatment resulted in no change of the levels of IL-4, IL-5, and IL-10 in the recall responses. There was no detectable level of IFN-{gamma} produced by the recall responses. Furthermore, the inhibition of endogenous IL-4 or IL-10 by the Ab treatments did not show the production of IFN-{gamma} (data not shown).

The prophylactic effects of chitin administration in the allergic C57BL/6 mouse

To further confirm the effects of chitin, we employed C57BL/6 mice, which are higher responders for cell-mediated immunity/Th1 responses, but lower responders for allergic responses compared with BALB/c mice. C57BL/6 mice were immunized with ragweed at the identical schedules (Table IGo). Serum IgE levels detected on day 14 (801 ± 357 ng/ml) were lower than those in ragweed-immunized BALB/c mice (Fig. 3GoA). After the treatment with chitin (5 mg/dose) on days -3 to 13, the levels decreased to 330 ± 158 ng/ml (p < 0.01, data not shown). Eosinophil levels were comparable with those found in BALB/c mice, and the chitin treatment resulted in a decrease in eosinophil numbers (Fig. 9Go).



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 9. The effect of chitin treatment on ragweed-induced eosinophilia in BAL of C57BL/6 mice. BAL was collected from the groups of C57BL/6 mice on day 14, which were immunized with ragweed and treated with chitin (5 mg/mouse/day), as indicated in Table IGo. Eosinophil numbers were determined as described in Materials and Methods. Control groups include unimmunized mice receiving i.t. challenge of saline (naive I) or ragweed 100 µg (naive II) on day 11. Mean ± SD, n = 6. *, p < 0.05 compared with the saline-treated group.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previously, we showed that phagocytosable nonantigenic chitin, a seemingly inert molecule, induces endogenous Th1 cytokines (IL-12, IL-18, TNF-{alpha}, IFN-{gamma}) (9, 10, 11). These are cytokines that are generally seen at early stages of infection (innate immunity) caused by intracellular bacteria such as M. bovis BCG (9, 10, 11). Innate immunity is important for protection against intracellular bacterial infections and to induce acquired immunity specific for bacteria (22). It is well established that Th1 cytokines, produced in innate immunity, down-regulate allergic immune (Th2) responses (18). The present study of recall responses clearly shows that allergen-stimulated IL-4, IL-5, and IL-10 production is significantly inhibited by the presence of chitin in the spleen cell cultures (Fig. 1Go). Our results suggest that IFN-{gamma} produced by NK cells, at least in part, is responsible for the inhibition of the production of these Th2 cytokines.

The provocative findings are that chitin, given orally, down-regulates allergen-induced IgE production and lung inflammation including eosinophilia in our ragweed-immunized allergic model. We also found that an increase in IFN-{gamma} levels and a reduction of IL-4 levels in BAL are associated with a reduction of allergen-specific IgE levels and an increase in allergen-specific IgG2a levels, indicating isotype switching by B cells. Interestingly, when chitin is given prophylactically, the chitin-treated mice appear to generate ragweed-specific Th1 cells, although the Th1 cell generation would significantly be reduced by endogenous IL-4 and IL-10, which are also produced during ragweed-stimulated recall responses. Our results strongly suggest that IFN-{gamma} produced by these Th1 cells as well as NK cells down-regulates IL-4-facilitated IgE formation and IL-5-facilitated eosinophil migration. However, ragweed-specific Th1 cells were not detected when chitin was given only during the effector phase of allergic inflammation. In this case, IFN-{gamma} produced by NK cells would play an important role for the down-regulation of IgE levels and lung eosinophilia.

Consistent with earlier observations (9, 23), our study clearly showed that IL-10 is produced by ragweed-stimulated CD4 cells and chitin-stimulated M{phi} and NK cells. In addition, IL-10 is produced by many other diverse cell populations, including bronchial epithelial cells and B cells (24, 25). The immunoregulatory roles of IL-10 for allergic responses appear to be complex. It has been suggested that IL-10 inhibits innate immunity as well as both Th1 and Th2 responses to Ags most probably by inhibiting APC (9, 21, 26). In our preliminary studies using IL-10-deficient C57BL/6 (KO) mice, sensitization with endotoxin-free ragweed in KO mice resulted in significantly higher levels of serum IgE levels and lung eosinophilia compared with those of allergic wild-type controls. The increases in serum IgE levels and lung eosinophil numbers in KO mice, both of which are facilitated by IL-4 and IL-5, respectively, were closely associated with the inhibitory effects of IL-10 on allergen-specific IL-4/IL-5 production in the recall responses. Oral administration of chitin at identical schedules employed in the present study significantly reduced serum IgE levels and lung eosinophilia in KO mice (manuscript in preparation). In sharp contrast to the anti-inflammatory effects, IL-10 may be highly relevant for proinflammatory responses involving mast cell activation: IL-10 significantly enhances mast cell proliferation, allergen-induced histamine release, and expression of chymases (27, 28). Therefore, exact regulatory mechanisms of endogenous IL-10, whose amounts can be controlled by the chitin treatment, remain to be elucidated.

Chitin, a polymer of N-acetyl-D-glucosamine, is an essential component of fungal cell walls and has been the target of antifungal drugs (nikkomycin Z, polyoxin D (29, 30)). Chitin is similar in structure to cellulose and has no mammalian counterpart. Following cellulose, chitin is the second most abundant polysaccharide found in nature. It comprises the horny substance in the exoskeleton of crabs, shrimp, and insects as well as the cell walls of fungi. Chitosan (deacetylated chitin) is nontoxic, nonallergenic, biodegradable, and biocompatible, and has been used in the development of a number of prostheses (artificial skin, contact lens, surgical sutures) that are widely used in medical and veterinary practice (31, 32). When chitin particles prepared as described above, essentially 100% N-acetyl-D-glucosamine, are administered to mice, they bind to the M{phi} plasma membrane mannose receptors (33). These receptors serve to mediate the interiorization of the chitin particles that, eventually, are degraded by lysozyme and N-acetyl-ß-D-glucosaminidase that are present in the M{phi} of humans and experimental animals (34, 35). Therefore, chitin preparations of nonmicrobial origin represent very attractive and highly effective products for the down-regulation of allergic inflammation. The oral administration for therapeusis/prophylaxis should most likely be the route of choice for children who suffer from allergic diseases.

In allergic animal models, the administration of IFN-{gamma} or IL-12 inhibits Th2-driven inflammation (6, 7, 8). Exogenous IL-12 induces IFN-{gamma} production, which is the most effective cytokine to down-regulate Th2 responses (7). The mechanisms for IFN-{gamma} production are comprehensive. Recently, an additional IFN-{gamma}-inducing factor (IL-18) was found to contribute to IFN-{gamma} production (36). We have confirmed that chitin induces M{phi} to produce IL-12, IL-18, and TNF-{alpha}, all of which act synergistically to induce IFN-{gamma} production by NK cells (9). Interestingly, chitin-stimulated M{phi} also produce IL-10, which up-regulates NK cell IFN-{gamma} production (9). It is, therefore, reasonable to speculate that amounts of exogenous IL-12 far greater than physiological ranges are required to induce effective levels of IFN-{gamma} production. Excessive doses of IL-12 would be associated with the toxic side effects (37, 38, 39).

Recently, it has been reported that treatment with live or HK bacteria, including M. bovis BCG, Mycobacterium vaccae, and Listeria monocytogenes, results in down-regulation of Th2 responses in various allergic mouse models (40, 41, 42). These bacterial suspensions are known to induce Th1 immune responses. Several bacterial components that induce Th1 cytokines have also been identified. Endotoxin, superantigen exotoxins, and mycobacterial DNA with CpG motifs are able to induce IL-12/TNF-{alpha}/IL-18 by M{phi} (43, 44, 45), suggesting usefulness of these components for the down-regulation of allergic inflammation (17, 46, 47). However, the toxic side effects of these components are of great concern (48). In the present studies, mice given chitin orally showed no visible adverse effects. Interestingly, their body weight tended to increase slightly compared with mice receiving saline (Table IIIGo).

The activity of chitin to induce Th1 cytokine production in vitro is found to be relatively stable under acidic conditions, although deacetylation can occur and deacetylated chitin (chitosan) does not induce Th1 cytokines (10). We found that the activity is unchanged after treatment with 0.1 M hydrochloric acid at 37°C for 4 h (data not shown). In addition, it is established that 1–10 µm poly(D-L-lactic-coglycolic acid) particles and polystyrene particles administered directly into the intestines following a laparotomy are readily internalized by Peyer’s patch M cells (49, 50). One would expect, therefore, that a part of the chitin particles given orally are taken up by M cells and translocated to the pocket region containing M{phi} and other leukocytes. During chitin mobilization in intraepithelial lymphoid tissues, some cells would produce Th1 cytokines. However, exact mechanisms of mucosal immunity in the small intestines stimulated by chitin remain to be elucidated.

Nonpathogenic and pathogenic facultative intracellular bacteria (for example, L. monocytogenes and M. tuberculosis) invade and survive in M{phi}, and only highly activated M{phi} can kill these bacteria. Since lifestyles in industrialized countries tend to create environments that eliminate/reduce bacteria (51), M{phi} activation levels that are promoted by such environments are substantially diminished. Studies using germfree experimental animals appear to support this hypothesis (52). Our study suggests that oral administration of chitin may be a substitute for such bacterial exposures.


    Acknowledgments
 
We thank Dr. W. James Metzger (East Carolina University School of Medicine) for his support of the initial part of this study, and Anastasia Sigounas for her technical support. We thank Dr. Robert M. Lust (East Carolina University School of Medicine) for his generous support of this project.


    Footnotes
 
1 This work was supported by grants from the American Lung Association, the East Carolina University School of Medicine, and the Pitt County Memorial Hospital Foundation, and North Carolina Biotechnology Center Grant 9805-ARG-0028. Back

2 Address correspondence and reprint requests to Dr. Yoshimi Shibata, Department of Physiology, East Carolina University School of Medicine, Greenville, NC 27858. E-mail address: Back

3 Abbreviations used in this paper: M{phi}, macrophage; BAL, bronchoalveolar lavage; BCG, bacillus Calmette-Guérin; HK, heat-killed; i.t., intratracheal; KO, knockout. Back

Received for publication March 17, 1999. Accepted for publication November 23, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Seaton, A., D. J. Godden, K. Brown. 1994. Increase in asthma: a more toxic environment or a more susceptible population?. Thorax 49:171.[Free Full Text]
  2. Shirakawa, T., T. Enomoto, S. Shimazu, J. M. Hopkin. 1997. The inverse association between tuberculosis responses and atopic disorder. Science 275:77.[Abstract/Free Full Text]
  3. Corry, D. B., H. G. Folksesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.[Abstract/Free Full Text]
  4. Foster, P. S., S. P. Hogen, A. J. Ramsay, K. I. Matthaei, I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.[Abstract/Free Full Text]
  5. Hogan, S. P., K. I. Matthaei, J. M. Young, A. Koskinen, I. G. Young, P. S. Foster. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161:1501.[Abstract/Free Full Text]
  6. Sur, S., J. Lam, P. Bouchard, A. Sigounas, D. Holbert, W. J. Metzger. 1996. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol. 157:4173.[Abstract]
  7. Gavett, S. H., D. J. O’Hearn, X. Li, S.-K. Huang, F. D. Finkelman, M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1527.[Abstract/Free Full Text]
  8. Iwamoto, I., H. Nakajima, H. Endo, S. Yoshida. 1993. Interferon {gamma} regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J. Exp. Med. 177:573.[Abstract/Free Full Text]
  9. Shibata, Y., L. A. Foster, M. Kurimoto, H. Okamura, R. M. Nakamura, K. Kawajiri, J. P. Justice, M. R. Van Scott, Q. N. Myrvik, W. J. Metzger. 1998. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-{gamma}-inducing factors but enhances NK cell production of IFN-{gamma}. J. Immunol. 161:4283.[Abstract/Free Full Text]
  10. Shibata, Y., L. A. Foster, W. J. Metzger, Q. N. Myrvik. 1997. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect. Immun. 65:1734.[Abstract]
  11. Shibata, Y., W. J. Metzger, Q. N. Myrvik. 1997. Chitin particle-induced cell mediated immunity is inhibited by mannan: mannose receptor-mediated phagocytosis initiates interleukin-12 production. J. Immunol. 159:2462.[Abstract/Free Full Text]
  12. Sutterwala, F. S., G. J. Noel, R. Clynes, D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor limitation. J. Exp. Med. 185:1977.[Abstract/Free Full Text]
  13. Skujins, J. J., H. J. Potgieter, M. Alexander. 1965. Dissolution of fungal cell walls by a streptomycete chitase and ß-(1->3) glucanase. Arch. Biochem. Biophys. 111:358.[Medline]
  14. Hunt, L. W., G. J. Gleich, T. Ohnishi, D. A. Weiler, E. S. Mansfield, H. Kita, S. Sur. 1994. Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am. J. Respir. Crit. Care Med. 149:1471.[Abstract]
  15. Petsch, D., T. C. Beeskow, F. B. Anspack, W. D. Deckwer. 1997. Membrane adsorbers for selective removal of bacterial endotoxin. J. Chromatogr. 693:79.
  16. Peng, Z., F. E. R. Simons, A. B. Becker. 1993. Measurement of ragweed-specific IgE in canine serum by use of enzyme-linked immunosorbent assays, containing polyclonal and monoclonal antibodies. Am. J. Vet. Res. 54:239.[Medline]
  17. Sur, S., J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, D. M. Klinman. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284.[Abstract/Free Full Text]
  18. Scott, P.. 1991. IFN-{gamma} modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.[Abstract]
  19. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O’Garra, K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an {alpha}-ß T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065.[Abstract/Free Full Text]
  20. Powrie, F., S. Menon, R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:3043.[Medline]
  21. Grünig, G., D. B. Corry, M. W. Leach, B. W. P. Seymour, V. P. Kurup, D. M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185:1089.[Abstract/Free Full Text]
  22. Bendelac, A., D. T. Fearon. 1997. Innate pathways that control acquired immunity. Curr. Opin. Immunol. 9:1.[Medline]
  23. Fiorentino, D. F., M. W. Bond, T. R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.[Abstract/Free Full Text]
  24. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is down-regulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257.[Abstract]
  25. Moore, K. W., A. O’Garra, R. De Waal Malefyt, P. Vieira, T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.[Medline]
  26. Dai, W., G. Koehler, F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158:2259.[Abstract]
  27. Lin, T. J., A. D. Befus. 1997. Differential regulation of mast cell function by IL-10 and stem cell factor. J. Immunol. 159:4015.[Abstract]
  28. Eklund, K. K., D. E. Humphries, Z. Xia, N. Ghildyal, D. S. Friend, V. Gross, R. L. Stevens. 1997. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-{alpha}, and the IL-10-induced expression of chymases. J. Immunol. 158:4373.[Abstract]
  29. Debono, M., R. S. Gordee. 1994. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48:471.[Medline]
  30. Nafsik, H. G., J. S. Tkacz. 1995. The fungal cell wall as a drug target. Trends Microbiol. 3:98.[Medline]
  31. Muzzarelli, R., B. Biagini, A. Pugnaloni, O. Filippini, V. Baldassarre, C. Castaldini, C. Rizzoli. 1989. Reconstruction of parodontal tissue with chitosan. Biomaterials 10:598.[Medline]
  32. Tanigawa, T., Y. Tanaka, H. Sashiwa, H. Saimoto, Y. Shigemasa. 1992. Various biological effects of chitin derivatives. ed. Advances in Chitin and Chitosan 206. Elsevier Applied Science, London and New York.
  33. Stahl, P. D., R. A. B. Ezekowitz. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10:50.[Medline]
  34. Bourbouze, R., R. Raffi, G. Dameron, H. Hali-Miraftab, F. Loko, J.-L. Vilde. 1991. N-acetyl-ß-D-glycosaminidase (NAG) isozymes released from human monocytes-derived macrophage in response to zymosan and human recombinant interferon-{gamma}. Clin. Chim. Acta 199:185.[Medline]
  35. Hirano, S., M. Iwata, K. Yamanaka, H. Tanaka, T. Toda, H. Inui. 1991. Enhancement of serum lysozyme activity by injecting a mixture of chitosan oligosaccharides intravenously in rabbits. Agric. Biol. Chem. 55:2623.
  36. Okamura, H., H. Tsutsui, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, et al 1995. Cloning of a new cytokine that induces IFN-{gamma} production by T cells. Nature 378:88.[Medline]
  37. Ryffel, B.. 1997. Interleukin-12: role of interferon-{gamma} in IL-12 adverse effects. Clin. Immunol. Immunopathol. 83:18.[Medline]
  38. Cohen, J.. 1995. IL-12 death: explanation and a puzzle. Science 270:901.
  39. Hendrzak, J. A., M. J. Brunda. 1995. Interleukin-12: biological activity, therapeutic utility, and role in disease. Lab. Invest. 72:619.[Medline]
  40. Erb, K. J., J. W. Holloway, A. Sobeck, H. Moll, G. L. Gros. 1998. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187:561.[Abstract/Free Full Text]
  41. Wang, C.-C., G. A. W. Rook. 1998. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 93:307.[Medline]
  42. Yeung, V. P., R. S. Gieni, D. T. Umetsu, R. H. DeKruyff. 1998. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J. Immunol. 161:4146.[Abstract/Free Full Text]
  43. Skeen, M. J., M. A. Miller, T. M. Shinnick, H. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production: activation of macrophage in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156:1196.[Abstract]
  44. Roman, M., E. Nartin-Orozco, J. S. Goodman, M.-D. Nguyen, Y. Sata, A. Ronaghy, R. S. Kornbluth, D. D. Richman, D. A. Carson, E. Raz. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849.[Medline]
  45. Yamamoto, S., E. Kuramoto, S. Shimada, T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-{alpha}/ß and -{gamma} with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866.[Medline]
  46. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555.[Abstract/Free Full Text]
  47. Broide, D., J. Schwarze, H. Tighe, T. Gifford, M.-D. Nguyen, S. Malek, J. Van Uden, E. Martin-Orozco, E. W. Gelfand, E. Raz. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054.[Abstract/Free Full Text]
  48. Cowdery, J. S., J. H. Chace, A.-K. Yi, A. M. Krieg. 1996. Bacterial DNA induces NK cells to produce IFN-{gamma} in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570.[Abstract]
  49. Ermark, T. H., E. P. Douherty, H. R. Bhagat, Z. Kabok, J. Pappo. 1995. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer’s patch M cells. Cell Tissue Res. 279:433.[Medline]
  50. Pappo, J., T. H. Ermak. 1989. Uptake and translocation of fluorescent latex particles by rabbit Peyer’s patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:144.[Medline]
  51. Rook, G. A. W., J. L. Stanford. 1998. Give us this day our daily germs. Immunol. Today 19:113.[Medline]
  52. Inagaki, H., T. Suzuki, K. Nomoto, Y. Yoshikai. 1996. Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin+ CD44+ T cells in sites of inflammation. Infect. Immun. 64:3280.[Abstract]



This article has been cited by other articles:


Home page
J. Immunol.Home page
C. A. Da Silva, C. Chalouni, A. Williams, D. Hartl, C. G. Lee, and J. A. Elias
Chitin Is a Size-Dependent Regulator of Macrophage TNF and IL-10 Production
J. Immunol., March 15, 2009; 182(6): 3573 - 3582.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Da Silva, D. Hartl, W. Liu, C. G. Lee, and J. A. Elias
TLR-2 and IL-17A in Chitin-Induced Macrophage Activation and Acute Inflammation
J. Immunol., September 15, 2008; 181(6): 4279 - 4286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Nishiyama, T. Shinohara, T. Pantuso, S. Tsuji, M. Yamashita, S. Shinohara, Q. N. Myrvik, R. A. Henriksen, and Y. Shibata
Depletion of cellular cholesterol enhances macrophage MAPK activation by chitin microparticles but not by heat-killed Mycobacterium bovis BCG
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C341 - C349.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Salagianni, W. K. Loon, M. J. Thomas, A. Noble, and D. M. Kemeny
An Essential Role for IL-18 in CD8 T Cell-Mediated Suppression of IgE Responses
J. Immunol., April 15, 2007; 178(8): 4771 - 4778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Sakai, H. Akiyama, Y. Sato, Y. Yoshioka, R. J. Linhardt, Y. Goda, T. Maitani, and T. Toida
Chondroitin Sulfate Intake Inhibits the IgE-mediated Allergic Response by Down-regulating Th2 Responses in Mice
J. Biol. Chem., July 21, 2006; 281(29): 19872 - 19880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Bierbaum, R. Nickel, A. Koch, S. Lau, K. A. Deichmann, U. Wahn, A. Superti-Furga, and A. Heinzmann
Polymorphisms and Haplotypes of Acid Mammalian Chitinase Are Associated with Bronchial Asthma
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1505 - 1509.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. Wills-Karp and C. L. Karp
Chitin Checking -- Novel Insights into Asthma
N. Engl. J. Med., September 30, 2004; 351(14): 1455 - 1457.
[Full Text] [PDF]


Home page
ScienceHome page
Z. Zhu, T. Zheng, R. J. Homer, Y.-K. Kim, N. Y. Chen, L. Cohn, Q. Hamid, and J. A. Elias
Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation
Science, June 11, 2004; 304(5677): 1678 - 1682.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Shibata, I. Honda, J. P. Justice, M. R. Van Scott, R. M. Nakamura, and Q. N. Myrvik
Th1 Adjuvant N-Acetyl-D-Glucosamine Polymer Up-Regulates Th1 Immunity but Down-Regulates Th2 Immunity against a Mycobacterial Protein (MPB-59) in Interleukin-10-Knockout and Wild-Type Mice
Infect. Immun., October 1, 2001; 69(10): 6123 - 6130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. P. Justice, Y. Shibata, S. Sur, J. Mustafa, M. Fan, and M. R. Van Scott
IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice
Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L363 - L368.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, Y.
Right arrow Articles by Myrvik, Q. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, Y.
Right arrow Articles by Myrvik, Q. N.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS